Oncology & Cancer

Many 'high-risk' Americans unconcerned about skin cancer

(HealthDay)—A new poll shows that only about 30 percent of American adults say they are concerned about developing skin cancer—even though nearly 70 percent have at least one risk factor for the disease.

Oncology & Cancer

'Suffocating' cancer: Improved melanoma immunotherapy

Hypoxia, or the inadequate oxygenation of a tissue, is a condition occurring frequently in all solid tumors such as melanoma skin cancer. Melanoma cells are not only able to survive oxygen deprivation, but also to use it ...

Oncology & Cancer

Barriers to physician skin exam ID'd for young melanoma survivors

(HealthDay)—Barriers to health care access, especially cost, are associated with increased odds of not having an annual physician skin examination (PSE) among young melanoma survivors, according to a research letter published ...

Oncology & Cancer

New immunotherapy drug effective for melanoma, other cancers

A new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients, a breakthrough that could extend to the treatment of other cancers. Relatlimab is the first immunotherapy treatment ...

Oncology & Cancer

Cancer has ripple effect on distant tissues

A new study with zebrafish shows that a deadly form of skin cancer—melanoma—alters the metabolism of healthy tissues elsewhere in the body. The research from Washington University in St. Louis suggests that these other ...

page 27 from 40